Aspiriant LLC’s iShares MSCI USA Momentum Factor ETF MTUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,265
Closed -$230K 294
2021
Q4
$230K Hold
1,265
0.01% 252
2021
Q3
$222K Hold
1,265
0.01% 218
2021
Q2
$219K Sell
1,265
-755
-37% -$128K 0.01% 224
2021
Q1
$325K Hold
2,020
0.02% 172
2020
Q4
$326K Hold
2,020
0.02% 168
2020
Q3
$298K Buy
+2,020
New +$289K 0.02% 182

Other funds holding MTUM

Aspiriant LLC's MTUM Position: Q1 2022 in Review

Aspiriant LLC sold out of iShares MSCI USA Momentum Factor ETF (MTUM) in Q1 2022, closing a stake of 1,265 shares — an estimated $230K sold.

Aspiriant LLC first reported a position in MTUM in Q3 2020 and held it in 6 quarters. The position peaked at $326K in Q4 2020. 677 funds tracked by Wall St. Rank hold MTUM as of Q1 2022.

  • Aspiriant LLC reported no remaining iShares MSCI USA Momentum Factor ETF position as of Q1 2022 after selling out during the quarter.
  • Aspiriant LLC sold 1,265 iShares MSCI USA Momentum Factor ETF shares in Q1 2022, an estimated $230K.
  • Aspiriant LLC first reported a position in iShares MSCI USA Momentum Factor ETF in Q3 2020 and held it in 6 quarters.
  • Aspiriant LLC's iShares MSCI USA Momentum Factor ETF position peaked at $326K in Q4 2020.
  • 677 funds tracked by Wall St. Rank held iShares MSCI USA Momentum Factor ETF as of Q1 2022.

Based on Aspiriant LLC's 13F filing for Q1 2022, filed 6 May 2022.